Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-911,288
| Closed | -$169M | – | 65 |
|
|
2025
Q2 | $169M | Sell |
911,288
-826
| -0.1% | -$154K | 0.49% | 38 |
|
|
2025
Q1 | $191M | Sell |
912,114
-59,779
| -6% | -$11.6M | 0.63% | 27 |
|
|
2024
Q4 | $173M | Buy |
971,893
+125,568
| +15% | +$23.1M | 0.52% | 38 |
|
|
2024
Q3 | $167M | Sell |
846,325
-197,492
| -19% | -$36.9M | 0.49% | 33 |
|
|
2024
Q2 | $179M | Sell |
1,043,817
-63,943
| -6% | -$10.6M | 0.53% | 35 |
|
|
2024
Q1 | $202M | Buy |
1,107,760
+40,675
| +4% | +$7.01M | 0.6% | 28 |
|
|
2023
Q4 | $165M | Sell |
1,067,085
-131,449
| -11% | -$19.2M | 0.53% | 35 |
|
|
2023
Q3 | $179M | Buy |
1,198,534
+298,125
| +33% | +$43.8M | 0.63% | 29 |
|
|
2023
Q2 | $121M | Buy |
900,409
+197,609
| +28% | +$29M | 0.4% | 55 |
|
|
2023
Q1 | $112M | Buy |
702,800
+225,151
| +47% | +$34.4M | 0.39% | 60 |
|
|
2022
Q4 | $77.2M | Buy |
477,649
+27,523
| +6% | +$4.22M | 0.28% | 97 |
|
|
2022
Q3 | $60.4M | Sell |
450,126
-98,834
| -18% | -$14.2M | 0.24% | 102 |
|
|
2022
Q2 | $84.1M | Sell |
548,960
-182,575
| -25% | -$27.9M | 0.31% | 72 |
|
|
2022
Q1 | $119M | Sell |
731,535
-296,812
| -29% | -$43.1M | 0.34% | 67 |
|
|
2021
Q4 | $139M | Sell |
1,028,347
-277,917
| -21% | -$32.8M | 0.36% | 64 |
|
|
2021
Q3 | $141M | Buy |
1,306,264
+300,804
| +30% | +$34.4M | 0.4% | 54 |
|
|
2021
Q2 | $113M | Buy |
1,005,460
+190,744
| +23% | +$21.5M | 0.32% | 69 |
|
|
2021
Q1 | $88.2M | Buy |
814,716
+44,223
| +6% | +$4.73M | 0.27% | 81 |
|
|
2020
Q4 | $82.6M | Buy |
770,493
+43,257
| +6% | +$4.16M | 0.26% | 93 |
|
|
2020
Q3 | $63.7M | Sell |
727,236
-68,842
| -9% | -$6.48M | 0.23% | 104 |
|
|
2020
Q2 | $78.2M | Buy |
796,078
+297,331
| +60% | +$26.2M | 0.31% | 74 |
|
|
2020
Q1 | $38M | Buy |
498,747
+133,800
| +37% | +$11.4M | 0.19% | 131 |
|
|
2019
Q4 | $32.3M | Sell |
364,947
-281,663
| -44% | -$23.4M | 0.13% | 198 |
|
|
2019
Q3 | $49M | Sell |
646,610
-48,497
| -7% | -$3.32M | 0.19% | 136 |
|
|
2019
Q2 | $50.5M | Sell |
695,107
-33,030
| -5% | -$2.6M | 0.2% | 143 |
|
|
2019
Q1 | $58.7M | Sell |
728,137
-56,675
| -7% | -$4.64M | 0.23% | 121 |
|
|
2018
Q4 | $72.4M | Sell |
784,812
-37,199
| -5% | -$3.27M | 0.32% | 81 |
|
|
2018
Q3 | $77.7M | Buy |
822,011
+2,162
| +0.3% | +$205K | 0.29% | 89 |
|
|
2018
Q2 | $76M | Sell |
819,849
-832,321
| -50% | -$81.3M | 0.29% | 91 |
|
|
2018
Q1 | $156M | Sell |
1,652,170
-399,615
| -19% | -$43.9M | 0.62% | 21 |
|
|
2017
Q4 | $198M | Buy |
2,051,785
+234,158
| +13% | +$22.1M | 0.78% | 13 |
|
|
2017
Q3 | $162M | Sell |
1,817,627
-73,778
| -4% | -$5.62M | 0.7% | 19 |
|
|
2017
Q2 | $137M | Sell |
1,891,405
-668,302
| -26% | -$44.9M | 0.62% | 25 |
|
|
2017
Q1 | $167M | Sell |
2,559,707
-213,275
| -8% | -$13.4M | 0.75% | 19 |
|
|
2016
Q4 | $174M | Sell |
2,772,982
-177,323
| -6% | -$10.8M | 0.81% | 16 |
|
|
2016
Q3 | $186M | Buy |
2,950,305
+15,394
| +0.5% | +$997K | 0.82% | 16 |
|
|
2016
Q2 | $182M | Sell |
2,934,911
-126,273
| -4% | -$7.69M | 0.81% | 15 |
|
|
2016
Q1 | $175M | Buy |
3,061,184
+1,304,557
| +74% | +$72.7M | 0.78% | 16 |
|
|
2015
Q4 | $104M | Buy |
1,756,627
+205,501
| +13% | +$11.8M | 0.45% | 48 |
|
|
2015
Q3 | $84.4M | Sell |
1,551,126
-19,707
| -1% | -$1.28M | 0.35% | 67 |
|
|
2015
Q2 | $106M | Buy |
1,570,833
+171,600
| +12% | +$11.2M | 0.42% | 53 |
|
|
2015
Q1 | $81.9M | Buy |
1,399,233
+206,167
| +17% | +$12.5M | 0.34% | 71 |
|
|
2014
Q4 | $78.1M | Buy |
1,193,066
+614,329
| +106% | +$38.7M | 0.31% | 82 |
|
|
2014
Q3 | $33.4M | Sell |
578,737
-41,388
| -7% | -$2.3M | 0.14% | 191 |
|
|
2014
Q2 | $35M | Buy |
620,125
+96,816
| +19% | +$5.08M | 0.15% | 185 |
|
|
2014
Q1 | $26.9M | Sell |
523,309
-117,883
| -18% | -$5.96M | 0.12% | 205 |
|
|
2013
Q4 | $33.9M | Buy |
641,192
+36,411
| +6% | +$1.79M | 0.15% | 180 |
|
|
2013
Q3 | $27.1M | Buy |
604,781
+284,505
| +89% | +$12.6M | 0.13% | 186 |
|
|
2013
Q2 | $13.2M | Buy |
+320,276
| New | +$14M | 0.07% | 281 |
|
Other funds holding ABBV
Axa's ABBV Position: Q3 2025 in Review
Axa sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 911,288 shares — an estimated $169M sold.
Axa first reported a position in ABBV in Q2 2013 and held it in 49 quarters. The position peaked at $202M in Q1 2024. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- Axa reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
- Axa sold 911,288 AbbVie shares in Q3 2025, an estimated $169M.
- Axa first reported a position in AbbVie in Q2 2013 and held it in 49 quarters.
- Axa's AbbVie position peaked at $202M in Q1 2024.
- 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.